Navigation Links
Alexza's AZ-004 (Staccato(R) Loxapine) Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients
Date:9/2/2008

nternet, at http://www.alexza.com, or via phone at 888-286-8010 for domestic callers or 617-801-6888 for international callers. The reference number for the replay of the call is 52049815.

About Acute Agitation

Acute agitation, characterized by unpleasant arousal, tension, irritability and hostility, is one of the most common and severe symptoms of many major psychiatric disorders, including schizophrenia and bipolar disorder. According to the National Institute of Mental Health (NIMH), bipolar disorder affects about 5.7 million American adults while schizophrenia afflicts about 2.4 million people in the United States. Market research among physicians and health-care providers indicates that over 90% of these patients will experience agitation during their lifetime and that about 70% of those who experience agitation will have one to six episodes per year.

Agitated patients are often treated in an emergency department, and are also treated as in-patients in psychiatric hospitals or psychiatric units in standard hospitals. Market research among psychiatrists indicates that these physicians currently treat acute agitation with intramuscular (IM) injections, rapid-dissolve tablets or standard tablets. IM injections are invasive, can be disconcerting to patients as they often require the use of restraints, and can be dangerous to the medical personnel while they attempt to inject the patient. IM injections can also take up to 60 minutes to work. Oral tablets provide convenience of dosing alternatives, but have a slower onset of action. This market research has also identified speed of onset as an important factor that affects the choice of therapy for treating acute agitation. Alexza believes that many patients with schizophrenia or bipolar disorder can make informed decisions regarding their treatment in an acute agitated state and would prefer a rapid-acting, noninvasive treatment.

In summar
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
2. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
3. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
4. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
5. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
6. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
7. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
8. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
9. Calabar AB Today Announced New Financing for Continuation of the Phase II Program in Patients With Dry Mouth
10. Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection
11. Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)...  Pomerantz LLP is investigating claims on behalf of ... (NASDAQ: VTAE ).  Such investors are advised ... rswilloughby@pomlaw.com or 888-476-6529, ext. 237. The ... and/or directors have violated Sections 10(b) and 20(a) of ... On February 27, 2015, the Company announced that its ...
(Date:2/27/2015)... N.J. , Feb. 27, 2015  Acsis Inc., ... and serialization solutions, announced today that John DiPalo ... a Supply & Demand Chain Executive 2015 ... executives who are leading initiatives to help prepare their ... of today,s business climate. This year,s list of Provider ...
(Date:2/27/2015)... - La ... monitoraggio dell,infarto congestizio (CHF - Congestive Heart Failure) ...   Vectorious Medical Technologies, società ... il monitoraggio cardiaco destinato a pazienti affetti da ... concluso una raccolta di finanziamenti per 5 milioni ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vitae Pharmaceuticals, Inc. - VTAE 2Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2Vectorious Medical Technologies completa una raccolta di 5 milioni di dollari 2
... NOVATO, Calif., Nov. 21, 2011 Ultragenyx Pharmaceutical, ... for rare and ultra-rare genetic disorders, today announced ... Chief Business Officer. Mr. Kassberg will be responsible ... strategic planning activities, as well as the human ...
... Nov. 21, 2011 Reportlinker.com announces that a ... catalogue: Medical Automation Technologies, Products ... REPORT SCOPE ... Since the enactment of the ...
Cached Medicine Technology:Ultragenyx Appoints Tom Kassberg as Chief Business Officer and Announces Management Team 2Ultragenyx Appoints Tom Kassberg as Chief Business Officer and Announces Management Team 3Ultragenyx Appoints Tom Kassberg as Chief Business Officer and Announces Management Team 4Medical Automation Technologies, Products and Markets 2Medical Automation Technologies, Products and Markets 3Medical Automation Technologies, Products and Markets 4Medical Automation Technologies, Products and Markets 5Medical Automation Technologies, Products and Markets 6Medical Automation Technologies, Products and Markets 7Medical Automation Technologies, Products and Markets 8Medical Automation Technologies, Products and Markets 9Medical Automation Technologies, Products and Markets 10Medical Automation Technologies, Products and Markets 11Medical Automation Technologies, Products and Markets 12Medical Automation Technologies, Products and Markets 13Medical Automation Technologies, Products and Markets 14Medical Automation Technologies, Products and Markets 15
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 Altec ... chosen as their Sage ERP Document Management Partner of ... 300 ERP, Sage CRM and other complimentary solutions for ... have worked side-by-side for many years to provide clients ... ERP applications. , “We are thrilled to recognize ...
(Date:2/27/2015)... In New York City, a Brooklyn dentist is ... care from his Sheepshead Bay­neighborhood practice. Dr. Leonard ... Heart, and will be hosting a charity event on ... are in need of fillings, extractions, or professional dental ... high­quality service of Dr. Umanoff's practice on the Dentistry ...
(Date:2/27/2015)... February 27, 2015 The federal court ... that allege use of the statin medication can increase ... issued a new order pertaining discovery in the cases ... Liebhard LLP comments. The Order, which was issued in ... February 25th, directs the parties to schedule certain witness ...
(Date:2/27/2015)... 27, 2015 According to court documents, ... on June 25, 2013 and underwent a procedure during ... her mouth. Because the duodenoscope allegedly had not ... antibiotic-resistant “superbug” carbapenem-resistant Enterobacteriaceae (CRE). , A ... Cook County on behalf of Ms. Pirolli alleging that ...
(Date:2/27/2015)... February 27, 2015 Adding to ... and pharmaceuticals, Benedict Advertising & Marketing has added ... client. The company’s patented NITROUSEAL® N20 closed mask ... method of sedation. , Sedation Systems, http://www.sedationsystems.com ... to a new level, though it focuses primarily ...
Breaking Medicine News(10 mins):Health News:Altec Announces 2014 Sage ERP Document Management Partner of the Year Award Recipient 2Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 2Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 3Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 2Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 3Health News:Lawsuit Alleges Blame on Scope Manufacturer for "Superbug" Outbreak 2Health News:Benedict Advertising & Marketing Signs Sedation Systems 2
... Casualty Company has,joined LifePlans, Inc. and the United States ... with senior Americans on fall prevention., "Over thirty-percent ... falls,are a leading cause of injury deaths and the ... of Bankers, a health and life,insurance company specializing in ...
... N.C., Jan. 17 With so much riding ... industry is continually,seeking to improve the expensive and ... leading firms are focusing more,marketing resources on the ... leader Best Practices, LLC., For instance, while ...
... Beaver County Board of,Commissioners is pleased to announce ... through Staunton Clinic, is providing,behavioral health services at ... Beaver Valley through UPMC,s Western Psychiatric Institute and,Clinic ... has,met its goal of being as seamless as ...
... hunt for human viruses described in this weeks issue ... found the cause of Kaposis sarcoma has revealed a ... deadly skin cancer called Merkel cell carcinoma. In the ... Feng, Ph.D., Masahiro Shuda, Ph.D., Yuan Chang, M.D., and ...
... Forsyth Institute launched a new one-of-a-kind service for ... Service (MIM) enables the rapid identification of bacterial ... Human Oral Microbe Identification Microarray (HOMIM), will focus ... cavity. Researchers can use this service to compare ...
... bring better treatments, researchers say , , THURSDAY, Jan. 17 (HealthDay ... of twins, scientists say they,re gaining new insight into how ... , The researchers report in a new study that both ... -- shared cells that mutated and became precancerous. In one ...
Cached Medicine News:Health News:Bankers Life and Casualty Company Joins LifePlans, Inc. and the Department of Health and Human Services to Launch Fall Prevention Program Study For America's Seniors 2Health News:Using Product Marketing to Launch Drugs That Outperform the Competition 2Health News:Transition of Behavioral Health Services from WPIC-BV to Heritage Valley Health System 2Health News:Newly discovered virus linked to deadly skin cancer 2Health News:Newly discovered virus linked to deadly skin cancer 3Health News:Newly discovered virus linked to deadly skin cancer 4Health News:Forsyth launches 1-of-a-kind core service to enable rapid identification of bacterial samples 2Health News:Study Gets Closer to Origins of Leukemia 2
... aluminum cuffs that can be bent to ... joint alignment, unique slot/screw adjustment mechanism allows ... cuff position. Cuffs are configured to offer ... with contractures.,The hinge can be locked in ...
... ACTION Elbow Wrap replaces messy taping and ... and others experiencing epicondylitis. Preferred by doctors ... non-bulky fit. Two overlay straps allow you ... foam lining holds the Elbow Wrap comfortably ...
... is designed to handle post-op elbow arthroscopy, ... Bledsoe Extender Arm Brace should be used ... the elbow is desired. In most cases, ... formed, fitted and adjusted in 5 minutes ...
... contour design of this lightweight brace allows it ... It stabilizes the ankle joint following severe sprains, ... semi-rigid spiral stays move with the ankle and ... help the splint control rotational strains on the ...
Medicine Products: